Sunniva (Sunniva) Common Stock : $89.81 Mil (As of Sep. 2019)

View and export this data going back to 2018. Start your Free Trial

What is Sunniva Common Stock?

Sunniva's quarterly common stock increased from Mar. 2019 ($87.09 Mil) to Jun. 2019 ($88.70 Mil) and increased from Jun. 2019 ($88.70 Mil) to Sep. 2019 ($89.81 Mil).

Sunniva's annual common stock increased from Dec. 2016 ($17.85 Mil) to Dec. 2017 ($41.90 Mil) and increased from Dec. 2017 ($41.90 Mil) to Dec. 2018 ($84.36 Mil).

Sunniva Common Stock Historical Data

The historical data trend for Sunniva's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Common Stock Chart

Sunniva Annual Data

Trend

Dec16

Dec17

Dec18

Common Stock

17.85

41.90

84.36

Sunniva Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Common Stock	Get a 7-Day Free Trial								70.94	84.36	87.09	88.70	89.81

Sunniva Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Sunniva (Sunniva) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (OTCPK:SNNVF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2

Website

https://www.sunniva.com

Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.